CD8A and neoplasm: Tumor antigens originated from specific gene mutations (Epping and Bernards, 2006) are presented by dendritic (DC) cells or directly presented by tumor cells (Jhunjhunwala et al., 2021) for priming of CD8+ T cells to eliminate tumor cells.